Geron recruits first patient in Imetelstat Phase 2 trial

Share: Email Story Twitter Facebook Stumbleupon Add to Any
by gordonrick | January 19, 2011 at 07:40 pm
118 views | 0 Recommendations | 0 comments

Geron has recruited first patient in an open-label Phase 2 clinical trial to investigate the activity of the company's telomerase inhibitor drug, Imetelstat (GRN163L), in patients with essential thrombocythemia (ET).

SOURCE

Advertisement
Share: email story | add to any | | facebook | stumbleupon

Most RecentMost Recommended Comments (0)

recommend Sign In or Join to post comments
in , , ,

closeSign in to NowPublic

Not a member?

JoinIt's free!

is reporting from
Member
NP Rank: